Gregory Essert on LinkedIn: Illumina Receives First FDA Emergency Use Authorization for a…
News Center | News and Press about Illumina
Press Release
Illumina, Inc. - Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders
Illumina, Inc. - Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
ACEGID and Illumina to Increase Africa's Genomics Capacity through Establishment of a Joint Training Academy – ACEGID
News Center | News and Press about Illumina
Investigation announced for long-term Investors in Illumina,
Press Release
Kevin Keegan on LinkedIn: Press Release
Illumina, Inc. - Illumina Deepens Commitment to Customers in China with New Manufacturing Site
Illumina, Inc. - Illumina collaborates with Nashville Biosciences to accelerate medicines development
News Center | News and Press about Illumina
Illumina, Inc. - Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States
Press Release
Illumina, Inc. - Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
Illumina, Inc. - Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023
Press Release
Illumina, Inc. - Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
3年拉扯，80亿美元收购案迎来终章！Illumina宣布剥离GRAIL | 基因科技门户
Illumina, Inc. - Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
